All News

An analysis of a large cohort of patients who chose noninvasive prenatal testing (NIPT) as a screening method for fetal trisomy 21, 18, and 13 (T21, T18 and T13) and sex chromosome aneuploidies (SCA) concluded there were extremely high detection rates and exceptionally low false positive rates.

During the 2021 American College of Obstetricians and Gynecologists Annual Clinical and Scientific Meeting, 3 experts—Kathryn Marko, MD, NCMP; Katherine T. Chen, MD, MPH; and Tamika Auguste, MD—led presentations on different types of mobile health apps and remote monitoring, as well as the role they play in patient care.

A presentation at the American College of Obstetrics and Gynecology’s (ACOG) Annual Clinical and Scientific Meeting, which started on April 30, discussed maternal mortality in pregnancy and how physicians can reduce rates.

Two leading experts provided ACOG ACSM attendees with a high-level overview on clinically valuable updates that may have been pushed to the backburner as COVID-19-related medical care dominated 2020.

If the oath “First, do no harm” is to be carried out by medical practitioners, one area in which this can truly be practiced involves the care of transmasculine or nonbinary patients who want to become pregnant or are already pregnant, according to a session from the 2021 American College of Obstetricians and Gynecologists (ACOG) Clinical and Scientific Meeting.

“When you leave populations behind from the data, you disadvantage the population that bears the brunt of the disease,” said Melissa Simon, MD, MPH, during her presentation on recommendations to improve women's health at this year's ACOG meeting.

A session held virtually at the American College of Obstetrics and Gynecology’s (ACOG) Annual Clinical and Scientific Meeting, which started on April 30, reviewed updates from its COVID-19 task force as we continue to witness the vaccine rollout.

A session held at the American College of Obstetricians and Gynecologists’s (ACOG) 2021 Annual Meeting highlighted the signs and obstacles when treating women and teens for PCOS.

Most guidance recommends a delay of at least 30 seconds in cord clamping following delivery. A presentation at the virtual 2021 Pediatric Academic Societies meeting looks at the research.

Diversity, equity, and inclusion (DEI) was a key theme that helped to kick off the annual meeting, which was held virtually. During the Hale Lecture: Diversity and Equity in Obstetrics and Gynecology – The Patient and the Provider – Care Delivery to Employment, several ob/gyns provided their own perspectives, including sharing data on diversity in the specialty now and its implications for the future pipeline.

Eva Chalas, MD, kicked off the Annual Clinical and Scientific Meeting as ACOG’s 71st president. Her keynote speech focused on her presidential initiative of personalized care. The goal was to provide guidance and tools to assist ob/gyns in enhancing access to comprehensive preventive care.

In a lightning round for the 2021 ACOG Annual Clinical and Scientific Meeting, David B. Nelson, MD, presented ‘Acute Fatty Liver of Pregnancy.’ Nelson is Chief of Obstetrics and Maternal Medical Director at Parkland Hospital. He is also Assistant Professor of Maternal-Fetal Medicine for the Department of Obstetrics and Gynecology at the University of Texas Southwestern Medical Center.

A panel discussion at the 2021 American College of Obstetrics and Gynecology’s (ACOG) Annual and Scientific Meeting, being held virtually April 30-May 2, offers insight into how the COVID-19 pandemic has changed telehealth in ob/gyn.

Contemporary OB/GYN®’s Associate Editor, Lindsey Carr, sat down with board member Yalda Afshar, MD, Ph.D., to discuss mental health and burnout in ob/gyn.

President Biden signed legislation extending the moratorium on a 2 percent Medicare cut.

Round two of the program will provide $249 million to support physicians by providing reimbursement of services necessary for telehealth.

This indication is approved under accelerated approval based on tumor response rate and durability of response.

A study offers much needed information on the rate of infant mortality in infants who have prenatal exposure to opioids.

Early and routine contraceptive counseling for all women of reproductive age with cardiovascular disease or cardiovascular risk factors is an essential component of comprehensive cardiovascular care, according to evidence-based recommendations of contraceptive options published in the Journal of the American College of Cardiology (JACC).

Women with diabetes are slightly less likely to use contraception after their diabetes diagnosis, according to a retrospective cohort study in the journal Primary Care Diabetes.

Contemporary OB/GYN®’s Associate Editor, Lindsey Carr, sat down with board member Yalda Afshar, MD, PhD, to discuss mental health and burnout in ob/gyn.

A look at what's coming to Contemporary OB/GYN® this week.

“Researching how obesity impacts menstrual blood loss is important to improve the ways we prevent and treat the debilitating symptom of heavy menstrual bleeding,” said Jacqueline Maybin, MBChB, PhD, senior research fellow and honorary consultant gynecologist at the MRC Centre for Reproductive Health at the University of Edinburgh.

It was a very busy week for the Contemporary OB/GYN team.

Nextstellis (drospirenone; estetrol) now is approved as a combined oral contraceptive for birth control.

New guidance from the American College of Obstetrics and Gynecologists (ACOG) calls on ob/gyns to recognize the prevalence of trauma and its impact on patients and health care teams and outlines the importance of trauma-informed approaches to delivery of care.

Transcervical fibroid ablation (TFA) to treat symptomatic uterine fibroids (UFs) is effective for a wide range of fibroid types and sizes, according to preliminary results of the first 160 women treated in the Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE registry).

Expanding coverage for noninvasive prenatal testing (NIPT) through a performance-based, risk-sharing agreement (PBRSA) resulted in a significant increase in NIPT use, a significant decrease in conventional prenatal screening methods, and a negligible increase in per member per month (PMPM) cost at Harvard Pilgrim Health Care (HPHC) in New England.